483
Kathryn Lucas, M.D.FDA 483 - Kathryn Lucas, M.D. - April 08, 2016
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kathryn J. Lucas, M.D. in Morehead City, NC, identified a significant deviation from the investigational plan for a Type 1 diabetes study. The firm enrolled subjects who did not meet the protocol's eligibility criteria regarding their diabetes diagnosis type and prior medication use. This failure to adhere to the study protocol raises concerns about the integrity of the clinical trial data.
Open in Dashboard
ID · 3342248a-b708-4835-a143-4f8503805302